Matches in Nanopublications for { ?s ?p "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.
- NP401773.RA8bdUkOPpQf-REwJsLalcEcF4zdBkN__MFfM72qaJMB0130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401773.RA8bdUkOPpQf-REwJsLalcEcF4zdBkN__MFfM72qaJMB0130_provenance.
- NP308459.RAXVX2My_3a8H3kPMll5YwymkgWk97YHKjSUbOk-lukRs130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308459.RAXVX2My_3a8H3kPMll5YwymkgWk97YHKjSUbOk-lukRs130_provenance.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.
- NP1352961.RANwfFRu3mtft8ZzywHSDUGR7kWa0exofrOFNIgokUoB4130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1352961.RANwfFRu3mtft8ZzywHSDUGR7kWa0exofrOFNIgokUoB4130_provenance.
- NP1352963.RAP6qwyDLtdxyS8OACWWz_6jkLUuGLKAQXOB93J_NOEUc130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1352963.RAP6qwyDLtdxyS8OACWWz_6jkLUuGLKAQXOB93J_NOEUc130_provenance.